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ABSTRACT
Gas-filled glass plasma electrodes coupled with high-frequency high-voltage generators are
used in medicine and dentistry for more than a century. In recent literature, therapeutic effects
of such procedure have been explained through topical bio-oxidative effects of ozone
generated by the dielectric barrier discharge. The aim of this study was to evaluate
characteristics of electric field and optical emission spectrum generated in the treatment field
by the glow discharge of the plasma electrode. Emission spectrum in red and near-infrared
wavelength range (540–886 nm) and pulsed electric field (impulse frequency 1053 Hz,
exponentially damped sine wave in the range of 33 kHz, duty cycle 20%) were recorded.
Estimated electric field strength at 1-mm distance was in the range from 5.8 to 13.7 kV/m and
between 106 and 108 V/m in the close proximity of electrode’s surface (below 0.01 mm).
Recorded factors are integral constituents in the treatment field and their properties can be
correlated to the known biological and therapeutic effects of photostimulation and
electrostimulation. These factors present important bioactive components which could be
responsible for therapeutic effects, reported in number of clinical studies, especially those







Sir William Crookes discovered plasma in 1879 using
electrical discharge tube with partial vacuum (Crooks
tube) [1]. Plasma, the fourth and most abundant fun-
damental state of matter, is made up of unbound
charged particles (electrons and ions) as well as pho-
tons, free radicals, metastable and neutral atoms and
molecules [2]. It is characterized by collective behav-
iour of the particles due to the long-range electromag-
netic (coulomb) forces, whereas the overall charge of
plasma is roughly zero [3].
Plasmas are classified with respect to the relative
temperature of their constituents as “thermal” and
“non-thermal”. In the thermal plasma all particles are
at the same temperature, whereas in the non-thermal
plasma ions and electrically neutral species are at a
much lower temperature than electrons. A specific
type of non-thermal plasma is cold atmospheric
plasma (CAP) produced at atmospheric pressure and
its temperature at the point of application is less than
40 C [4]. Thanks to the low temperature and the pos-
sibility of its application on living tissue as well as the
numerous bioactive properties of CAP, a whole new
field of plasma medicine is established [5,6].
Plasma, excluding solid-state plasmas or phenom-
ena like lightning and aurora, does not occur naturally
at the surface of the Earth [3]. Hence for investiga-
tions of plasmas and their technological applications
they must be produced artificially. Currently, substan-
tial efforts are being made in plasma medicine to
develop the best-suited plasma device for the given
medical indication [4,6]. There are numerous device
configurations, which differ in their geometry, num-
ber and location of electrodes, and the nature of initi-
ating and sustaining electric or electromagnetic fields
(EMFs), which have been recognized as the most suit-
able and cost-effective sources for the production of
CAP [4].
CAP used for healthcare can be dated back as early
as the middle of the nineteenth century [6]. CAP devi-
ces comprised gas-filled glass electrode (plasma elec-
trode) coupled with high-frequency high-voltage
source (namely Tesla coil) are applied in medicine for
more than one century, and millions of treatments
were performed through such method [7–9]. However,
due to the lack of basic and practical research, their
therapeutic applicability is still unrecognized by the
scientific and medical community.
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A plasma electrode is a sealed partially evacuated
glass tube filled with air, noble gas or other gas mix-
tures in which high-voltage high-frequency oscillating
current causes formation of, apparently homoge-
neous, diffuse discharges (Figure 1(a)) which are
referred to as radio-frequency glow discharges [10].
For the purpose of the therapeutic procedure, plasma
electrode is applied either directly to the patient skin
and mucosa or is brought at distance of few milli-
metres from their surface (Figure 1(b–d)) [9]. In the
later, generation of dielectric barrier discharge
(DBD), which consists of numerous micro-discharges,
is obtained in the air gap between the electrode and
the treated surface. By applying a sufficient electric
field, which is larger than the dielectric strength of the
air (3 £ 106 V/m) [11], a local breakdown is initiated
in which growing electron avalanches quickly produce
such a high space charge that self-propagating stream-
ers are formed (Figure 1(b–c)) [10]. For more than a
century, DBD is used for generation of ozone,
but recently its ability to generate CAP has been rec-
ognized [12].
In recent years, therapeutic method using CAP
devices comprised plasma electrode coupled with
high-frequency, high-voltage source re-entered clinical
application in medicine and dentistry. A clinical evalu-
ation of such method indicates positive results in disin-
fection [13–15] post-surgical soft tissue and bone
healing and pain relief [16–20], treatment of various
oral and dental diseases [21–24], reduction of tempo-
romandibular disorder-related pain [25], and
bisphosphonate-related osteonecrosis of the jaw [26].
In recent available literature found on the clinical
application of plasma electrode coupled with high-fre-
quency generator, all of the reported therapeutic effects
are generally ascribed to bio-oxidative effects of ozone
[14-26].
When gaseous ozone is administered in the treat-
ment field, e.g. using ozone-producing syringe as
described in our recent paper [13], the therapeutic
effects can indeed be ascribed exclusively to ozone
[27]. Similarly, when ozone is produced through DBD
and CAP generation, in the air gap between plasma
electrode and treated surface as reported by Tuncer
Figure 1. Glow discharge of the plasma electrode: (a) lens-shaped plasma electrode in standby mode (tenuous glow discharge
inside the lumen of the glass tube); (b) initial DBD streamer is formed as the electrode approaches the surface of the skin (glow dis-
charge is still tenuous); (c) developed DBD in the air gap as the distance between electrode and skin is reduced (intensified glow
discharge); (d) plasma electrode in direct contact with skin (intensified glow discharge without visible DBD).
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et al. [14] or Wilczynska et al. [15], the positive thera-
peutic effects could be ascribed to a topical antiseptic
and bio-simulative effects of both ozone and CAP [4].
Graves [28] gave detailed background on CAP’s under-
lying therapeutic mechanisms emphasizing the role of
reactive oxygen and nitrogen species as the most
important therapeutic agents in the course of CAP
treatment. However, in the treatment modes when
plasma electrode is applied in direct contact with the
treated surface (especially in treatment of tissues
underlying intact skin) or is immersed in liquids (e.g.
saliva or blood), in which DBD and ozone generation
are limited or even missing (Figure 1(d)), therapeutic
effects, like improved bone healing and pain reduction,
are still observed [17–19,25].
Erdemci et al. [29], in the study in which they have
used short-duration treatments with plasma electrode
on the extraction wound (AL probe, 30 s, 80% output
intensity, at days 0 and 2), presumed that preoperative
topical application of ozone was too distant to affect
the alveolus and during the postoperative period the
presence of a clot in the socket may have prevented the
ozone reaching and affecting the bony surfaces of the
alveolus. On the other hand, Filipovic et al. [16]
reported the intensity of pain and other discomforts,
after surgical extraction of the impacted third lower
molar, were significantly more reduced in patients who
received the “ozone” therapy through single postopera-
tive treatment of an extraction wound with combined
ozone gas (ozone-producing syringe, KP probe, for 40
s) and plasma electrode application (AL and GI probe,
40 s each, at 80% output intensity).
Furthermore, Kazancioglu et al. [17] reported that
degree of pain and the number of analgesic tablets
taken was significantly lower after extra-oral applica-
tion of the plasma electrode at the insertion point of
the masseter muscle after the third molar extraction
(Omega probe, 80% intensity for 10 min on postopera-
tive days 0, 1, 3, 5 and 7) but were not able to explain
how ozone contributed to the regulation and/or inhibi-
tion of the transmission of the pain signal to the cen-
tral nervous system. Kazancioglu et al. [18] also
demonstrated that both plasma electrode (120 s, three
times a week for two weeks) and laser treatments (808
nm; 0.1 W, 4 J/cm) had a positive effect on bone for-
mation in rat calvarial defect.
Ozdemir et al. [19] reported results which demon-
strate that application of plasma electrode (PA probe at
80% for 30 s, three times a week for two weeks) aug-
ments new bone formation and leads to a simultaneous
amplification of osteoblasts after the bone graft surgery.
Taşdemir et al. [20] reported plasma electrode applica-
tion (CA probe for 30 s at 75% at days 0 and 1, and
30% at day 2 post-surgically), in early healing period of
de-epithelialized gingival graft, enhanced blood perfu-
sion units in the first postoperative week. They also
reported improvement in wound healing accompanied
by an increase in the quality of life and decrease in post-
operative pain. Dogan et al. [25] reported application of
the plasma electrode (Omega probe, for 10 min, three
times in one week) applied to the skin in the projection
of underlying temporomandibular joint (TMJ) to be
more effective treatment than medication therapy for
relieving TMJ-related pain.
In view of the above clinical reports [17–19,25], we
propose a hypothesis that not only bio-oxidative effects
of ozone but also the effects of emission spectrum and
electric field, which are generated by the glow dis-
charge of the plasma electrode (Figure 1), and there-
fore are present in the treatment field, have to be taken
into consideration as bioactive components in course
of such treatment. By our knowledge, there are no
reports in the appropriate literature regarding the pres-
ence or quantification of the named factors in the
treatment field during the procedure. Assuming that
these factors could have significant role in the course
of treatment, we conducted investigation with an aim
to confirm their presence and evaluate their properties
in the treatment field. We report results of the electric
field and optical emission spectrum measurements of
the plasma electrode’s glow discharge and compare
them, with respect to their properties, with biological
and therapeutic effects of photostimulation and elec-
trostimulation recognized by the relevant literature.
Materials and methods
Investigated device
Ozonix generator (Biozonix GmbH, Munich, Ger-
many) was used in investigations described in this
paper. The used model consists of a central unit, a
patient grounding, an applicator and different models
of plasma electrodes designed for intra- and extra-oral
application in dentistry (Figure 2). The lens-shaped
plasma electrode having the diameter of 8 mm (GI
probe, product number 1005, Biozonix GmbH,
Munich, Germany) was selected and its glow discharge
investigated (Figure 2). In the menu of the central unit,
the output intensity from 10% to 100% (output voltage
Table 1. Wavelengths of the most evident lines in the emission
spectrum of the glow discharge of the recorded at distance of
60 mm from the lens-shaped part of the plasma electrode.
Spectrum of neutral neon atom (Ne I) (nm)
540.06 602.99 630.48 667.83 743.89 849.53
576.44 607.43 632.82 671.7 748.89 859.12
585.24 609.62 633.44 692.95 753.57 863.46
588.19 612.85 638.3 702.41 754.40 865.43
590.64 614.31 640.23 703.24 793.69 878.06
594.48 616.36 650.65 705.13 794.32 885.38
596.55 618.22 653.29 705.91 830.03 886.57
597.55 621.73 659.9 717.39 837.76
598.79 626.65 665.21 724.52 841.84
Spectrum of neutral oxygen atom (O I) (nm)
700.23 777.54 777.19 844.63
The most expressive lines.
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from 3 to 18 kV, according to manufacturer) was
adjusted depending on the requirements of the
investigation.
In order to differ the factors generated by the glow
discharge of the plasma electrode from the factors gen-
erated by DBD, all measurements were carried out for
the standby mode of the electrode (see Figure 1(a)).
Thus, measurements were done at sufficient distances
from lens-shaped surface of the electrode which pre-
cluded closed circuit (DBD or direct contact) between
electrode and notional treated surface, i.e. measure-
ment equipment.
Optical emission spectroscopy
The emission spectrum of the electrode’s glow dis-
charge was recorded using an AvaSpec-3648 Fiber
Optic Spectrometer (Avantes, Apeldoorn, The Nether-
lands) with 10-mm slit and wavelength range 200–
1100 nm, lens of which was placed at the distance of
60 mm from the plasma electrode. Maximum output
intensity (100%) was chosen in the menu of Ozonix
device. AvaLight-DH-CAL source was used to calibrate
for absolute spectral intensity in the range 200–
1099 nm. Time of signal integration in all the measure-
ments was 500 ms. Data acquisition was done by Ava-
Soft-All software package. The NIST data base was
used for the identification of atomic spectral lines and
spectral simulation of spectra [30].
Electric field measurement
The oscilloscope used for the measurement of electric
field strength, generated by the glow discharge of the
plasma electrode, was WaveRunner 640Zi (Teledyne
LeCroy Inc., CA, USA), the input impedance of which
is 1 MV jj 14 pF. A 16-mm-long monopole antenna
(wire AWG 16) was installed via a BNC connector on
a ground plane (1.6 mm thick FR-4 glass epoxy panel
laminated with copper layer on both sides, 1 m £ 1 m
in size). Antenna and ground plane were connected to
the oscilloscope and the patient grounding electrode of
Ozonix device was connected to the ground plane. The
applicator with the electrode was mounted on the anti-
static expanded polystyrene holder which allowed pre-
cise positioning of plasma electrode in relation to
antenna. In order to eliminate the influence of mea-
surement equipment on the electric field of the elec-
trode as well as to protect sensitive electronics of the
oscilloscope, the distance of 10 mm between the
antenna and plasma electrode (in which no DBD can
occur) was determined as the closest “safe” distance at
which measurements were conducted. The measured
data were used for extrapolation of electric filed
strength in the close proximity of the plasma electro-
de’s surface (below 10 mm).
In all the measurements, the distance between the
ground plane and the lowest point of the lens-shaped
part of the plasma electrode was 10 mm. The distance
between lens-shaped surface of the electrode and the
antenna was changed in steps of 10 mm for interval
from 10 mm up to 100 mm. At each distance between
the antenna and lens-shaped surface of the electrode
voltage waveforms were recorded for 10 different out-
put intensities (10%–100% in steps of 10%) and the
data were processed and analysed by MATLAB
R2015b (MathWorks, Natick, MA, USA).
The relationship between the electric field strength
(E) and induced open-circuit voltage (Uoc), measured
on the terminals of a dipole antenna (as a monopole
antenna, over a perfect conductive surface, has the
same radiation pattern as a dipole antenna), is given
by [31]
Figure 2. Ozonix generator used in this investigation: (a) gen-
erator; (b) patient grounding electrode; (c) applicator; (d) glass
plasma electrode (for application in dentistry different shapes
of electrodes are available, e.g. GI, AL, CA, PA probe); (e) inves-
tigated lens-shaped plasma electrode (GI probe, product num-
ber 1005, diameter = 8 mm) recommended for disinfection
and stimulation of soft tissues; (f) ozone-producing syringe (KP
probe) recommended for installation of gaseous ozone in
treatment of root canals and periodontal pockets; (g) double
plasma electrode (Omega probe) recommended for extra-oral
treatment of pain and TMD (data according to manufacturer
Biozonix GmbH, Munich, Germany – image created by Doma-
goj Prebeg).
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E ¼ 4Uoc½2Inðia
1Þ  2 In4
i½2 Inðia1Þ  1 (1)
where, l is the physical length of dipole antenna a is its
radius. For l = 32 mm and a = 0.6554 mm, characteris-




The electric field strength (E) is expressed in V/m.
Results and discussion
Emission spectrum analysis
Plasma electrode’s glow discharge emission spectrum
was recorded at 60-mm distance from the lens-shaped
part of the electrode (Figure 3).
Spectral lines recorded in the red and near-infrared
(R-NIR) wavelength range from 540 to 886 nm are
shown in Figure 3. In the region below 540 and above
886 nm, no spectral lines were recorded. The most
expressive spectral lines are recorded at 585, 588, 594,
602, 607, 609, 614, 616, 626, 632, 633, 640, 650, 653,
659, 667, 671, 692, 705, 724, 743 and 837 nm. These
lines were identified as the atomic lines of neutral neon
(Ne I). The spectral lines recorded at 700, 777 and
844 nm can be ascribed to neutral oxygen atom (O I).
A spectral simulation of neon spectra showed elec-
tron excitation temperature between 0.5 and 0.75 eV
and of oxygen spectra 0.25 eV, respectively. Properties
of spectrum can be attributed to excitation and conse-
quent relaxation of neon and oxygen atoms, which are
present in the glow discharge of investigated plasma
electrode. Dissociation energy of oxygen double bond
is 5.15 eV whereas the lowest excitation energy of neon
is 16.6 eV, which indicates relatively high energy of
electrons which are present inside the glass chamber of
plasma electrode [30].
It is reasonable to assume that the irradiance of
recorded spectrum is additionally increased when
plasma electrode is placed at the shorter distance from
the treated surface, or when brought into direct contact
with the treated surface. This assumption is evidenced
by observed light scattering through translucent tissues
during the clinical application of plasma electrode as
well as increased brightness of the glow discharge in the
case of closed circuit (DBD or direct contact) between
the electrode and the treated surface (Figure 1).
Convissar [32], in his book, reported a wide spec-
trum of applications and positive results of photo-bio-
modulation in dental medicine. Numerous papers
reported that irradiation with low-level R-NIR light
(600–900 nm) shows wide variety of effects on tissues
and on the cellular level, especially mitochondria and
electron transport chain [33–36]. Karu [34] stated that
a variety of diseases have definitively been demon-
strated to depend on mitochondrial functions; this
then makes it possible that the low-level light irradia-
tion of mitochondria can affect their pathophysiologi-
cal function.
Although mechanisms of photo-biomodulation are
still not fully elucidated, most of the relevant studies
indicate possible adsorption of light by the mitochon-
drial enzymes (especially wavelengths 613.5–623.5,
632.8, 667.5–683.7, 750.7–772.3 and 812.5–846.0 nm)
[33–36]. Passarela and Karu [35] reported that irradia-
tion with low-level monochromatic (laser) and narrow
band (LED) light in specified spectrum can lead to
stimulation of neuronal growth and of DNA and RNA
synthesis; promotion of cell adhesion; improved neu-
rological function; acceleration of wound healing; cel-
lular and extracellular matrix proliferation; collagen
production and granulation tissue formation; and
reduction of the inflammatory response. With respect
to the results of current study, it may be concluded
that the emission spectrum of the plasma electrode
coincides with the above-specified spectrum which
shows bio-modulating properties.
Absorption of R-NIR spectrum may lead to local
temperature increase; excitation of flavin and cyto-
chrome in mitochondrial respiratory chain with conse-
quent influence on transport of electrons; production
of reactive oxygen species through excitation of endog-
enous porphyrins; and photo-activation of calcium
channels with increase of intracellular calcium concen-
tration and consequent cellular proliferation [34,36].
Reports regarding the application of R-NIR spectrum
also indicate positive results in the early phase of
wound healing of bone defects [37], osteogenic differ-
entiation in mesenchymal stem cells [38] and dental
pulp stem cells [39], as well as the improved bone heal-
ing and reduction of loading time of dental implants
[40]. Therefore, it is reasonable to assume that R-NIR
Figure 3. Emission spectrum of the plasma electrode’s glow
discharge in the range from 540 to 886 nm recorded at dis-
tance of 60 mm from the lens-shaped surface of the plasma
electrode.
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spectrum emitted by the glow discharge of plasma elec-
trode might have an important role in stimulation of
regenerative processes, which is also evidenced by sev-
eral clinical studies in which bone and soft tissue
regeneration is reported [18–20].
Chen et al. [41] in their meta-analysis (14 reports)
concluded that R-NIR light therapy did not signifi-
cantly reduce pain but did significantly improved the
functional outcomes of patients with temporomandib-
ular disorders (TMDs). Panhoca et al. [42] showed
that low-level R-NIR photo-stimulation can be useful
in improving outcomes related to pain relief and man-
dibular range of motion for TMD patients, while de
Castro et al. [43] reported reduction of inflammatory
infiltrate in the TMJ. These effects could explain simi-
lar results reported by Dogan et al. [25] for extra-oral
application of plasma electrodes in direct contact with
the skin in projection of the underlying TMJ.
However, although wavelengths of the spectral lines
emitted by the glow discharge of the plasma electrode
correspond to the bioactive R-NIR wavelengths speci-
fied in a number of scientific papers, to validate the
range of their biological effects and therapeutic value,
it would be necessary to carry out further radiometric
measurements which would determine power, radiant
energy, radiant exposure and pulse parameters of the
emitted spectrum.
Electric field analysis
Pulsed voltage waveforms (impulse frequency:
1053 Hz) were recorded in the treatment field.
Impulses were characterized by the exponentially
damped sine waveform in the range of 33 kHz
(Figure 4).
The values of maximum amplitude voltage (Uoc) as
a function of distance (from 10 to 100 mm) for all
output intensities (10%–100% in steps of 10%) ranging
from X § SD = 0.27 § 0.06 V (at 100 mm) to X § SD
= 5.56 § 1.29 V (at 10 mm) were recorded (Figure 5).
Electric field strength values were calculated from
maximum amplitude voltage values (2) for all intensi-
ties (10%–100%) and distances (10–100 mm) from the
lens-shaped surface of the electrode (Appendix 1). At
100-mm distance from the electrode’s surface, the elec-
tric field strength ranged from 12.44 V/m at 10%
intensity to 28.46 V/m at 100% (X § SD = 22.15 §
5.04 V/m) and at 10-mm distance from 248.86 to
587.32 V/m (X § SD = 451.69 § 105.13 V/m), respec-
tively (Figure 6).
The power function (E = U/db) showed the closest
fitting to experimental results. Functions for maximum
(E = 13,702/d1,305, R2 = 0.9863) and minimum (E =
5855.8/d1,294, R2 = 0.9809) output intensities, where l d
= 1 mm (Figure 7). Functions were used to approxi-
mate the electric field strength in the close proximity
(below 10 mm) to the plasma electrode’s surface
(Figure 8). In such way, estimated electric field
strength was in the range from 5.8 to 13.7 kV/m at 1-
mm distance and between 106 and 108 V/m in the close
proximity of electrode’s surface (below 0.01 mm).
Figure 4. Voltage waveform recorded at 100% output intensity
and 10-mm distance with pulse frequency 1053 Hz, exponen-
tially damped sine wave in range of 33 kHz, pulse duration 200
ms – duty cycle 20%. Maximum amplitude voltage (arrow) was
used for the calculation of the electric field strength.
Figure 5. Maximum amplitude voltage (V) measured on mono-
pole antenna with respect to distance (10–100 mm) and out-
put intensity (10%–100%).
Figure 6. Electric field strength (V/m) increases with the
increase of output intensity and with the reduction of distance
although the reduction of distance shows higher impact (steep
incline of the plane on the distance axis).
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The electric field in the air above the earth’s surface
is typically 100 V/m, but during strong electric storms,
it may increase 10-fold or more [44]. Due to the insig-
nificant transmission of low-intensity fields through
air by radiation, such fields are usually applied through
direct contact of the electrode and skin. Hence, we can
assume that relatively low-intensity field applied at 10-
mm distance from the treated surface probably has no
significant biological effect.
However, the trend of increase of electric field
strength with reduction of distance described by power
function (E = U/db) and extrapolated values of the elec-
tric field strength indicate relatively high values of elec-
tric field in close proximity of the electrode (Figure 8).
In such way, estimated values of electric field are in
range from 106 to 108 V/m in the close proximity of
electrode’s surface (below 0.01 mm). Such approxima-
tion is in line with the electric field strength which is
considered as precondition for achievement of electric
breakdown in the air gap (3 £ 106 V/m) [11].
Constant U in proposed power function (Figure 5
(a)) also estimates the voltage of the plasma electrode
(U = E £ db) to be in range from 5.8 kV (at 10% inten-
sity) to 13.7 kV (at 100%) which can be related to the
manufacturer’s technical data (output voltage between
3 and 18 kV). According to Paschen’s law, such derived
values of electrode’s voltage define the value of p £ d
(55–220 mmHg£ cm) predicting the distance between
the surface of the electrode and treated surface (at
atmospheric pressure), at which electrical breakdown
in air can occur, to be in the range <0.9 mm (at 10%
intensity) to <3.1 mm (at 100%) [11]. These results
are also in favour of clinical observations in which
DBD indeed can be generated only below these distan-
ces depending on the chosen output intensity of the
device.
Here it has to be emphasized that the estimated val-
ues of electric field only represent conditions in
standby mode of the electrode. In the case of the closed
circuit (DBD or direct contact) between plasma elec-
trode and treated surface, the voltage and electric field
of the electrode will certainly be significantly lowered
due to the flow of the electric current.
Xiao [11] stated that the electric discharge in air
gap, in addition to electric field strength and distance
between electrodes, will depend on numerous other
factors, e.g. the shape of the electrode, uniformity of
the electric field and the voltage rise time. Therefore,
numerous corrective factors are used in case of extrap-
olation of electric field strength in air gap discharges
where additional complex physical mechanisms can
cause fluctuations in electric field [45]. In such case
both constants (U and b) in the proposed power func-
tion could be significantly altered. The values of the
electric field strength in the case of direct contact of
the plasma electrode and tissue or liquid will addition-
ally be dependent on the current density and electric
properties of the treated medium, e.g. resistivity, con-
ductivity and/or impedance, as well as the applied fre-
quency [46].
Although the primary function of the investigated
system, according to manufacturer, is production of
ozone by means of DBD, in the appropriate available
literature, electric field generated by plasma electrode
is not considered as an active component in the treat-
ment field [16–25]. Medical appliances using low-to-
moderate intensity radio-frequency electromagnetic
fields (RF-EMF) in the range from 30 kHz to 300 MHz
are commonly used in the treatment of bone fractures,
wounds or pain, and oedema [44]. Kumaran and Wat-
son [47,48], in their review articles (120 reports) on
therapeutic effects of RF-EMF, listed numerous clinical
studies reporting positive effects in reduction of pain,
oedema, erythema, inflammatory processes, stimula-
tion of healing and re-establishment of function, as
well as reduced analgesic drug intake and reduced
length of hospitalization. Al-Badavi et al. [49] also
Figure 7. Power function (E = U/db) fitting the experimental
results for minimum (10%) and maximum (100%) output inten-
sity (shown in logarithmic scale).
Figure 8. Estimated values of the electric field strength (V/m)
for minimum and maximum output intensities predict a dielec-
tric strength of air (3 MV/m) to be exceeded in the close prox-
imity (<0.01 mm) electrode (show in logarithmic scale).
AUTOMATIKA 7
reported application of pulsed radio-frequency
(impulse frequency 600 Hz, pulse modulation
250 kHz) as safe and effective treatment for TMJ
arthralgia and increasing mandibular range of motion.
With respect to the recorded characteristics of the elec-
tric field, it can be assumed that certain therapeutic
effects could be correlated with the interaction of the
electric field and treated tissues. Therefore, this effects
should be taken into consideration, especially in the
line of explanation of therapeutic effects reported by
several author s [17–19, 25], which could not be
explained by topical bio-oxidative effects of ozone.
Biological effects of EMFs are ascribed to thermal
and non-thermal mechanisms. Application of thermal
effects of EMF may vary from mild (diathermy: <41
C) to high (thermal ablation: from 46 to 110 C)
increase of tissue temperature [50]. Thermal impacts
are dependent on a variety of EMF parameters, such as
intensity, pulse shape and width, and the pulse
sequence type [51]. Most of the therapeutic effects
ascribed to mild increase of temperature involve
increased metabolic activity and vasodilatation with
increased perfusion of the treated tissue [52]. Thermal
effects have indeed been recognized by Dogan et al.
[25] who reported that during the application of
plasma electrode, patients did not feel pain, although
they felt a mild increase in temperature in the tempo-
romandibular region. It can be assumed this effect
could have been induced, by both, the absorption of R-
NIR light as well as the thermal effects of the electric
field. In this sense, the thermometric analysis of a treat-
ment field would give valuable insight on the range of
local thermal effects of such treatment.
The most detectable non-thermal mechanism of
interaction of the EMF and tissues is the effect of cellu-
lar excitation by ion efflux (movement of calcium and
other ions) through voltage gated ion channels sensi-
tive to the oscillating electric fields [53]. Dysfunction
of neuronal calcium signalling has been linked to
neuro-inflammatory and neurodegenerative processes
[54]. Calcium metabolism has also been recognized as
an important factor involved in regenerative processes
[55]. Therefore, a possibility to influence calcium
metabolism by externally applied electric fields has
important clinical implications. This mechanism could
also explain healing and pain reduction effects
recorded in application of plasma electrode [16–
20,25]. This is especially the cases when plasma elec-
trode was used extra-orally in direct contact with skin
in the projection of underlying jaw or TMJ [17,25].
Due to the induced charge on its surface, a cell
polarization and movement (dielectrophoresis) as well
as formation of large aqueous pores (electroporation)
may occur. Wang [53] stated that low values of electric
field do not cause electroporation but with the increase
of field strength or pulse duration, various effects may
be observed, i.e. gene transfection (104 V/m and pulse
duration 20 ms), drug delivery (>105 V/m,<10 ms) or
bacterial decontamination (105 to >106 V/m in micro-
second range). With respect to properties of the
recorded pulsed electric field (especially due to expo-
nentially damped sine waveform character shown in
Figure 2), it would be reasonable to assume that it
might induce a wide spectrum of non-thermal effects
from cell polarization to bacteria decontamination.
However, due to the complex physical phenomena
which occur in treatment field in the case of closed cir-
cuit (DBD or direct contact) between plasma electrode
and treated surface, the scope of exact biological impli-
cations remain unclear. Therefore, the results obtained
in this investigation do not allow further interpretation
as implementation of fluid and plasma dynamics as
well as bio-impedance models would be necessary in
order to understand this implication more accurately.
In order to precisely determine therapeutic window
and possible biological impacts of the recorded electric
field on treated tissues, a further research is needed,
which would quantify properties and define in situ
dynamics of the electric currents, voltage drops, energy
distribution and dissipation during closed-circuit
modes.
Conclusion
The results of present study confirm that properties of
the factors, recorded in the treatment field, can be cor-
related with mechanisms underlying photostimulation
[34,35] and electrostimulation [56,57]. Hence, these
mechanisms should be considered in order to fully
explain therapeutic effects achieved through the appli-
cation of plasma electrode, regardless of the modality
of its application. It is reasonable to assume that the
electric field and emission spectrum of a plasma elec-
trode’s glow discharge, as well as already recognized
ozone and CAP, produce a cumulative effect on the
treated tissue. The properties and therapeutic contri-
bution of individual factors will most certainly depend
on the mode of administration (electrode positioning,
intensity and duration of exposure) as well as the prop-
erties of treated tissues. This is also evidenced by a
broad spectrum of recorded clinical scores with respect
to the different modes, sites and durations of applica-
tion [14–26]. Possible therapeutic effects of electric
field and R-NIR irradiation are especially substantiated
by the reports in which it is not possible to explain
obtained results through topical effects of gaseous
ozone [17–19,25].
Complex conditions present in the treatment field,
inability to isolate individual factors without
compromising other factors in the treatment field, as
well as similar therapeutic effects reported for each of
its constituents [28,32,52] present a major challenge in
terms of defining the appropriate model which would
explain mechanisms underlying such therapeutic
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procedure. Therefore, a more extensive multidisciplin-
ary investigation is needed in order to evaluate physical
properties and dynamics of these factors and elucidate
exact mechanisms in which therapeutic effects are
achieved.
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Appendix 1. Strength of the electric field (V/m) recorded for different output intensities
(10%–100%) and distances (10–100 mm) from the lens-shaped surface of the plasma
electrode.
Intensity
d (mm) 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
10 248 327 388 429 466 485 503 520 556 586
20 118 150 181 201 211 226 232 242 262 267
30 84 105 125 135 145 155 161 171 176 186
40 59 73 85 95 100 105 110 115 120 125
50 41 52 61 69 72 77 78 82 88 91
60 31 40 47 53 57 59 60 64 68 71
70 25 31 38 42 45 47 49 51 54 56
80 20 25 30 33 35 37 38 40 42 44
90 15 19 23 26 28 29 30 31 33 34
100 12 16 19 21 23 24 25 26 27 28
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